OOIR: Observatory of International Research

Papers

(The median citation count of Heart Failure Reviews is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making	49
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction	38
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis	37
The cardiosplenic axis: the prognostic role of the spleen in heart failure	34
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction	28
The role of TAVR in patients with heart failure: do we have the responses to all questions?	27
Correction to: Is it time to revisit ICD indications?	26
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?	24
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition	24
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?	21
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers	20
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyond	19
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease	19
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging	19
Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure	17
Targeting mitochondrial dysfunction with elamipretide	16
Left ventricular assist device in cardiac amyloidosis: friend or foe?	15
ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study	15
Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review	12
Letter to the Editor	11
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021	10
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy	8
Experimental heart failure models in small animals	8
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era	8
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature	7

Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases	6
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure	6
Soluble ST2: a valuable prognostic marker in heart failure	6
Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools	6